Related references
Note: Only part of the references are listed.Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa
Cristina Cigana et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Phage therapy for severe bacterial infections: a narrative review
Aleksandra Petrovic Fabijan et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
Aleksandra Petrovic Fabijan et al.
NATURE MICROBIOLOGY (2020)
The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
Matthias I. Groeschel et al.
NATURE COMMUNICATIONS (2020)
Hit Identification of New Potent PqsR Antagonists as Inhibitors of Quorum Sensing in Planktonic and Biofilm Grown Pseudomonas aeruginosa
Fadi Soukarieh et al.
FRONTIERS IN CHEMISTRY (2020)
Phage Therapy in the Year 2035
Jean-Paul Pirnay
FRONTIERS IN MICROBIOLOGY (2020)
Identification and Characterization of New Bacteriophages to Control Multidrug-ResistantPseudomonas aeruginosaBiofilm on Endotracheal Tubes
Viviane C. Oliveira et al.
FRONTIERS IN MICROBIOLOGY (2020)
Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization
Rachel Yoon Kyung Chang et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2020)
Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model
Marco Cafora et al.
SCIENTIFIC REPORTS (2019)
Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study
Martin Wallin et al.
BMC PULMONARY MEDICINE (2019)
CFTR Protects against Mycobacterium abscessus Infection by Fine-Tuning Host Oxidative Defenses
Audrey Bernut et al.
CELL REPORTS (2019)
Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
Thaysa Leite Tagliaferri et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient
Nancy Law et al.
INFECTION (2019)
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Rebekah M. Dedrick et al.
NATURE MEDICINE (2019)
BIOMEDICINE Multivascular networks and functional intravascular topologies within biocompatible hydrogels
Bagrat Grigoryan et al.
SCIENCE (2019)
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
Saima Aslam et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus
Mian Li Ooi et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2019)
Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure
Rosanna C. T. Wright et al.
MBIO (2019)
Transplanting organs from pigs to humans
Megan Sykes et al.
SCIENCE IMMUNOLOGY (2019)
Ethics codes and use of new and innovative drugs
Jan Borysowski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
Patrick Jault et al.
LANCET INFECTIOUS DISEASES (2019)
Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot
Mario Gajdacs et al.
HEALTH SERVICES RESEARCH AND MANAGERIAL EPIDEMIOLOGY (2019)
Visualisation of Multiple Tight Junctional Complexes in Human Airway Epithelial Cells
Alysia G. Buckley et al.
BIOLOGICAL PROCEDURES ONLINE (2018)
Effects of human rhinovirus on epithelial barrier integrity and function in children with asthma
K. Looi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections
Rachit Agarwal et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Defining antimicrobial resistance in cystic fibrosis
Timothy J. Kidd et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
Maria del Carmen Parquet et al.
FRONTIERS IN MICROBIOLOGY (2018)
Consistent success in life-supporting porcine cardiac xenotransplantation
Matthias Laengin et al.
NATURE (2018)
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
Lucy L. Furfaro et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance
Varsha Shriram et al.
FRONTIERS IN MICROBIOLOGY (2018)
Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis
Stephanie Trend et al.
FRONTIERS IN PHARMACOLOGY (2018)
Synthetic Immunotherapeutics against Gram-negative Pathogens
Mary Sabulski Feigman et al.
CELL CHEMICAL BIOLOGY (2018)
Phage treatment of an aortic graft infected with & IT;Pseudomonas aeruginosa & IT;
Benjamin K. Chan et al.
EVOLUTION MEDICINE AND PUBLIC HEALTH (2018)
Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs
Jeremy Puthumana et al.
JAMA NETWORK OPEN (2018)
Development of an airway mucus defect in the cystic fibrosis rat
Susan E. Birket et al.
JCI INSIGHT (2018)
Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection
Rachel Y. Chang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
A Pan-Genomic Approach to Understand the Basis of Host Adaptation in Achromobacter
Julie Jeukens et al.
GENOME BIOLOGY AND EVOLUTION (2017)
The AREST CF experience in biobanking - More than just tissues, tubes and time
Luke W. Garratt et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler
Nicholas B. Carrigy et al.
PHARMACEUTICAL RESEARCH (2017)
Conditionally reprogrammed primary airway epithelial cells maintain morphology, lineage and disease specific functional characteristics
Kelly M. Martinovich et al.
SCIENTIFIC REPORTS (2017)
Overview of FDA's Expanded Access Program for Investigational Drugs
Jonathan P. Jarow et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2017)
The isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6
Danielle L. Peters et al.
PLOS ONE (2017)
Access to unregistered drugs in Australia
Peter Donovan
AUSTRALIAN PRESCRIBER (2017)
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Danish J. Malik et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2017)
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres
Daniel J. Smith et al.
RESPIROLOGY (2016)
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
R. Andres Floto et al.
THORAX (2016)
Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets
Iram J. Haq et al.
THORAX (2016)
Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms
Justine Monnerat Tinoco et al.
ARCHIVES OF ORAL BIOLOGY (2016)
Organogenesis of adult lung in a dish: Differentiation, disease and therapy
Jinwook Choi et al.
DEVELOPMENTAL BIOLOGY (2016)
Effect of human rhinovirus infection on airway epithelium tight junction protein disassembly and transepithelial permeability
Kevin Looi et al.
EXPERIMENTAL LUNG RESEARCH (2016)
Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis
Tavs Qvist et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Gudio Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Biofilms: an emergent form of bacterial life
Hans-Curt Flemming et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Nina Chanishvili
CURRENT DRUG DELIVERY (2016)
Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy
Maciej Zaczek et al.
FRONTIERS IN MICROBIOLOGY (2016)
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
Miqueias Lopes-Pacheco
FRONTIERS IN PHARMACOLOGY (2016)
Infection in cystic fibrosis: impact of the environment and climate
K. A. Ramsay et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2016)
Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh
Shafiqul Alam Sarker et al.
EBIOMEDICINE (2016)
An Optimised Human Cell Culture Model for Alveolar Epithelial Transport
Hui Ren et al.
PLOS ONE (2016)
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections
Cristina Cigana et al.
SCIENTIFIC REPORTS (2016)
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Benjamin K. Chan et al.
SCIENTIFIC REPORTS (2016)
A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection
H. K. Bayes et al.
SCIENTIFIC REPORTS (2016)
An overview of Compassionate Use Programs in the European Union member states
Gayathri Balasubramanian et al.
INTRACTABLE & RARE DISEASES RESEARCH (2016)
New In Vitro Model To Study the Effect of Human Simulated Antibiotic Concentrations on Bacterial Biofilms
Janus A. J. Haagensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity
Danielle L. Peters et al.
BMC GENOMICS (2015)
D-Enantiomeric Peptides that Eradicate Wild-Type and Multidrug-Resistant Biofilms and Protect against Lethal Pseudomonas aeruginosa Infections
Cesar de la Fuente-Nunez et al.
CHEMISTRY & BIOLOGY (2015)
Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection
Tavs Qvist et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients
Jaspreet Singh Sahota et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2015)
Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials
Dieter Vandenheuvel et al.
ANNUAL REVIEW OF VIROLOGY, VOL 2 (2015)
Experience of the Eliava Institute in bacteriophage therapy
Mzia Kutateladze
VIROLOGICA SINICA (2015)
Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity
Fatima Kamal et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis
Rasmus Lykke Marvig et al.
NATURE GENETICS (2015)
Lung Phenotype of Juvenile and Adult Cystic Fibrosis Transmembrane Conductance Regulator-Knockout Ferrets
Xingshen Sun et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Twenty-Five-Year Outbreak of Pseudomonas aeruginosa Infecting Individuals with Cystic Fibrosis: Identification of the Prairie Epidemic Strain
Michael D. Parkins et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout Rats
Katherine L. Tuggle et al.
PLOS ONE (2014)
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Marcella Facchini et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres
Timothy J. Kidd et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
A peptide-morpholino oligomer conjugate targeting Staphylococcus aureus gyrA mRNA improves healing in an infected mouse cutaneous wound model
Andrew J. Sawyer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients
Sanja Stanojevic et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Gene-Silencing Antisense Oligomers Inhibit Acinetobacter Growth In Vitro and In Vivo
Bruce L. Geller et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Re-evolution of the 2-Phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance
Stefano Sabatini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
Colleen T. O'Loughlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa
Petar Knezevic et al.
RESEARCH IN MICROBIOLOGY (2013)
Bactericidal Antibiotics Induce Mitochondrial Dysfunction and Oxidative Damage in Mammalian Cells
Sameer Kalghatgi et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Bursting the bubble on bacterial biofilms: a flow cell methodology
Shanika A. Crusz et al.
BIOFOULING (2012)
Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections
Joanne L. Fothergill et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Synergistic Action of Gentamicin and Bacteriophage in a Continuous Culture Population of Staphylococcus aureus
Amy E. Kirby
PLOS ONE (2012)
Bacteriophages φMR299-2 and φNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells
Debebe Alemayehu et al.
MBIO (2012)
Innate Inflammatory Responses of Pediatric Cystic Fibrosis Airway Epithelial Cells Effects of Nonviral and Viral Stimulation
Erika N. Sutanto et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Quorum Sensing Inhibitors Increase the Susceptibility of Bacterial Biofilms to Antibiotics In Vitro and In Vivo
Gilles Brackman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The ΔF508 Mutation Causes CFTR Misprocessing and Cystic Fibrosis-Like Disease in Pigs
Lynda S. Ostedgaard et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Economic burden ofPseudomonas aeruginosainfection in patients with cystic fibrosis
Sujit S. Sansgiry et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Produces Abnormalities in Tracheal Development in Neonatal Pigs and Young Children
David K. Meyerholz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis
Xingshen Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
Charles R. Esther et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Changes in Cystic Fibrosis Sputum Microbiology in the United States Between 1995 and 2008
Julia Emerson et al.
PEDIATRIC PULMONOLOGY (2010)
Pseudomonas aeruginosa Microevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence
Alessandra Bragonzi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis Cells
Sophie Moreau-Marquis et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Samiya Razvi et al.
CHEST (2009)
Pharmacokinetics and Pharmacodynamics of Antibacterial Agents
Matthew E. Levison et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005
F. A. Millar et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Pseudomonas aeruginosa Biofilms in the Respiratory Tract of Cystic Fibrosis Patients
Thomas Bjarnsholt et al.
PEDIATRIC PULMONOLOGY (2009)
Human host defense peptide LL-37 prevents bacterial biofilm formation
Joerg Overhage et al.
INFECTION AND IMMUNITY (2008)
Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets
Xingshen Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
Helle Krogh Johansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Phage therapy experience at the Eliava Institute
M. Kutateladze et al.
MEDECINE ET MALADIES INFECTIEUSES (2008)
Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway
Sophie Moreau-Marquis et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2008)
Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs
Christopher S. Rogers et al.
SCIENCE (2008)
Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets
Miriam E. R. Darnell et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients
Lars Jelsbak et al.
INFECTION AND IMMUNITY (2007)
Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen
Ute Muh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis
LA Kalish et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model
A Bragonzi et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance
P Salunkhe et al.
JOURNAL OF BACTERIOLOGY (2005)
Novel mouse model of chronic pseudomonas aeruginosa lung infection mimicking cystic fibrosis
N Hoffmann et al.
INFECTION AND IMMUNITY (2005)
Isolation and characterization of novel giant Stenotrophomonas maltophilia phage φSMA5
HC Chang et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells:: development of an alveolo-capillary barrier in vitro
MI Hermanns et al.
LABORATORY INVESTIGATION (2004)
Development of cystic fibrosis and noncystic fibrosis airway cell lines
J Zabner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection
FT Coleman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na+] and pH but elevated viscosity
S Jayaraman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
JL Burns et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis
M Sanguinetti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
